Table 4.

Comparison of each marker between the groups of non-PEU, PEU without pseudopolyposis, and PEU with pseudopolyposis

Variable	Non-PEU	PEU without pseudopolyposis	PEU with pseudopolyposis	Kruskal–Wallis test	Post-hoc test
	(n = 34)	(n = 16)	(n = 11)	P-value	P1	P2	P3
Alb (g/dL), median [IQR]	4.7 [4.1–5.2]	4.6 [3.8–5.5]	4.5 [3.8–4.9]	0.624	0.998	0.638	0.660
Hb (g/dL), median [IQR]	14.4 [11.2–16.7]	14.8 [12.4–17.9]	14.0 [11.6–18.7]	0.634	0.564	0.962	0.967
CRP (mg/dL), median [IQR]	0.03 [0.02–0.18]	0.06 [0.02–1.46]	0.06 [0.02–0.35]	0.014	0.017	0.159	0.96
FIT (ng/mL), median [IQR]	30 [30–1670]	30 [30–178]	30 [30–1830]	0.712	0.945	0.673	0.916
FC (mg/kg), median [IQR]	54.4 [3.8–721]	122 [8.9–1780]	316 [11.9–2499]	0.014	0.232	0.022	0.255

PEU past extensive ulcer, P1 non-PEU vs. PEU without pseudopolyposis, P2 non-PEU vs. PEU with pseudopolyposis, P3 PEU without pseudopolyposis vs. PEU with pseudopolyposis, Alb albumin, IQR interquartile range, CRP C-reactive protein, Hb hemoglobin, FIT fecal immunochemical occult blood test, FC fecal calprotectin